Obstructive sleep apnea syndrome surgery studies largely evaluate single procedures or procedure combinations in case series designs, but it can be difficult to compare results across studies. The authors present a standardized format for presentation of surgical study results to facilitate pooled analyses and subgroup analyses. The format includes thorough characterization of baseline subject characteristics and the use of outcome measures that reflect the spectrum of obstructive sleep apnea and its consequences. As the apneahypopnea index is the most common, albeit controversial, primary outcome measure in obstructive sleep apnea syndrome surgery studies, the authors propose analysis and reporting standards to facilitate understanding its role as an outcome measure. Because surgical outcomes vary according to subject characteristics, investigators should also evaluate the potential association between baseline subject characteristics and outcomes.
T he literature concerning the definitive (as opposed to adjunctive) surgical treatment of obstructive sleep apnea syndrome (OSA) consists primarily of case series studies, although randomized surgical trials and cohort studies exist. [1] [2] [3] The OSA surgery studies largely evaluate single procedures or procedure combinations without a direct comparison of alternative treatments within a single study. Comparisons of results across case series studies have been performed, but these are limited without standardized formats for presentation of study results. 1, 2, 4 While multi-institutional, randomized surgical trials can potentially provide generalizable, high-level evidence, there are numerous challenges to conducting these studies, including those related to ethics, feasibility, and study design. In light of these barriers, the available literature, including case series studies, is relevant. Nevertheless, there is potential to make the reporting of OSA surgery study results even more valuable.
A framework for reporting results from OSA surgical trials, regardless of study design, will enhance study interpretation, improve patient care, address fundamental unanswered questions, and direct future investigations ( Table 1 ). In this commentary, we focus on reporting of baseline characteristics, outcome measures, and the analysis of results, including statistical analysis. Previous publications have described unique methodology considerations for OSA surgical trials, 5 and this framework complements rather than replaces these discussions.
Baseline Characteristics Subject Factors Are Associated with Outcomes of OSA Surgical Treatments
Individual procedures and procedure combinations vary widely in results for individual subjects and across studies. 2 Although some results are due to differences in surgical technique and variability in outcome measurement, a substantial portion may be related to differences in baseline subject characteristics. Complete presentation of baseline characteristics and the evaluation of associations with outcomes may clarify the underlying mechanisms. Explicit characterization of subjects will establish the generalizability of results, allow for pooled data analyses, and enable subgroup analyses.
Reporting of the following baseline subject characteristics is recommended:
• demographic factors (eg, age, gender, race, and ethnicity); • study eligibility criteria, including intolerance to positive airway pressure, and a full reporting of the number who did and did not meet eligibility criteria; • baseline sleep study results when relevant, with sleep study technique and explicit criteria used for interpretation and scoring of disordered breathing events; • clinical characteristics, including those used as selection criteria and those potentially associated with outcomes (body mass index, tonsil size, modified Mallampati position, Friedman stage, nasal obstruction, and findings of other airway evaluations such as awake endoscopy, lateral cephalogram, or druginduced sleep endoscopy); and
• subject-based and/or objective measures of physical, functional, and emotional consequences.
Outcome Measures OSA Treatment Is Not Solely a Number
Whether the number in question is the change in the apneahypopnea index (AHI), the percentage of subjects who achieved an arbitrary response to treatment, or some other metric, the use of single numbers in reporting trial outcomes oversimplifies the complexity of OSA disease burden and treatment outcome. As a surrogate outcome, the AHI is a standard but not a sufficient examination of treatment outcomes, as it does not capture the spectrum of OSA and clinically meaningful endpoints completely.
Whenever possible, clinical outcomes should be measured primarily in preference to surrogate outcomes. 6 While the AHI defines OSA severity, it and other sleep study parameters are surrogate measures. The AHI is the most common primary study endpoint, but other sleep study parameters may be more reliable and physiologically more important (eg, apnea index, desaturation index, percentage of sleep time with oxygen saturation below 90%). OSA treatment is based not only on Otolaryngology-Head and Neck Surgery 144 (4) improving breathing patterns during sleep but also on alleviating the health-related (primarily cardiovascular and endocrine), behavioral (daytime sleepiness, quality of life), functional (performance, reaction time, driving), and social (disruptive snoring) consequences of the disorder, all of which must be weighed against surgical complications and side effects. The AHI and other sleep study results are intermediate measures poorly associated with many clinical outcomes at baseline, and it is unclear whether treatment-related changes in the AHI are associated with changes in these other potential consequences. OSA surgical treatment studies commonly report the changes in AHI but often do not report other endpoints.
Although objective measures minimize the potential placebo effect that can occur with any treatment, subjective endpoints are valuable.
All medical and surgical treatments may have a substantial placebo effect, particularly with regard to subjective outcomes. The placebo-controlled trial is one method of evaluating a potential placebo effect Although there are placebo-controlled trials for minimally invasive OSA surgical treatments, 7,8 the successful completion of such surgical trials is more challenging methodologically than for medications and may be impossible for many invasive procedures. Other controlled trial designs are available that provide higher level evidence than case series, including comparisons to alternative treatment or no treatment. Objective outcomes are possible for some endpoints but can be cumbersome, expensive, or unavailable. Valid, reliable measures can evaluate subjective outcomes, with specific statistical and analytical approaches to evaluate potential placebo effects.
Analysis of Results
In longitudinal studies (eg, case series or cohort studies), preoperative and postoperative values of all outcome measures should be reported along with 95% confidence intervals around the difference. The paired t test will evaluate for statistically significant changes in continuous outcome measures, and the confidence interval will evaluate the possibility of clinically meaningful differences.
Data collected at baseline and following surgery in the same group of subjects are considered paired. The Student t test compares the mean and standard deviation of the preoperative and postoperative data but does not account for the paired nature of the data. With paired data, the paired t test is preferred because it has greater statistical power and is therefore (appropriately) more likely to show a statistically significant difference than a Student t test.
In Controlled Studies, Changes in Outcomes Should Be Tested Between Groups
The between-group comparisons are not paired, so the standard Student t test is appropriate, although the paired t test can evaluate for changes within each group individually. Technically, when assumptions of normality are not met, comparable nonparametric tests should be used (ie, Mann-Whitney test). The calculation of the 95% confidence interval around the difference, along with knowledge of the size of a clinically meaningful difference, helps interpret the clinical significance of results.
Changes in the AHI (or other primary outcome measure) should be reported alongside other outcome measures, with a comparison of changes in the former with the latter.
Because OSA treatment studies commonly employ a primary outcome that is a surrogate measure, such as the AHI, it is essential to determine whether changes in the AHI mirror those for other (eg, health-related, behavioral, and functional) outcomes. These comparisons can also define the extent to which the AHI should be the primary outcome measure in OSA surgical studies. To the extent that the AHI is a meaningful objective outcome, this comparison may be particularly important for subjective outcomes, where it can help differentiate treatment and placebo effects.
There is no evidence-based definition of effective surgical OSA treatment, and presentation of results in absolute terms and according to specific criteria will help define target outcomes.
For positive airway pressure, one common definition of adequate compliance is use of at least 4 hours per night on at least 5 nights per week, but this is based on very limited evidence and represents a relatively small fraction of recommended sleep time (20 vs 49-56 hours per week). OSA surgical studies have used the AHI as the primary outcome, and commonly used definitions of response are based on little or no evidence. Arbitrary thresholds such as a reduction in the AHI of at least 50% to an absolute level below 15 or 20 events/h without oxygen desaturation have been severely criticized. 1, 2 Some have argued for a more stringent threshold requiring a postoperative AHI below 5 events/h, 9 but all of these proposed criteria are not evidence based.
For studies with the AHI as the primary outcome, we propose presentation of data in aggregate (absolute change in the AHI) as well as subgroup analyses based on distinct definitions of treatment response, including a reduction of at least 50% in the AHI to levels below 20, 15, 10, and 5 events/h. Eventually, these data may establish an evidence basis for defining an effective treatment threshold for responders, if one truly exists, based on whether specific subgroups do or do not have changes in secondary outcome measures. For example, assuming use of the AHI as the primary outcome, if there is a reduction in blood pressure and/or improvement in sleeprelated quality of life in subjects who achieve a reduction in the AHI below 5 but not 10, 15, or 20 events/h, this would suggest that the former is a more appropriate definition of treatment response. Use of the AHI and arbitrary cut points may prove useless, but presentation of data in a standard format will enable an evaluation. Presentation of subject-level data will enable pooling of data across multiple studies. Potential alternatives for evaluating the postoperative AHI include a change in the median index, the percentage reduction with surgery, or mathematical calculations that equate the residual index to a degree of positive airway pressure compliance. 10 All or some of these can complement the above cut points. The timing of postoperative sleep studies relative to the surgery date should be reported.
The examination of subject factors associated with outcomes is essential.
Differences in baseline subject characteristics explain some variation in reported surgical outcomes. Although some OSA surgical studies have identified associations between outcomes and subject factors, many studies have not examined them. Statistical analysis should explore potential associations between outcomes and baseline characteristics, whether demographic factors or findings of specific preoperative evaluation techniques. For variable baseline characteristics such as body mass index or body weight, paired t tests should consider changes following surgery, and statistical techniques (eg, regression analysis, multivariate analysis of variance, multivariate analysis of covariance) enable adjustment. Subgroup analyses, while often only hypothesis generating, will help identify predictors of surgical outcomes and surgical indications.
Statistical analysis requires a combination of tests and caveats, with an understanding of the distinction between statistical and clinical significance.
This framework proposes what for many studies would be an expanded analysis plan, for which it is critical to use statistical tests appropriately and judiciously. With a greater number of statistical tests, patterns (such as the consistency of changes across outcome measures) are likely more important than individual results of statistical significance, and the Bonferroni correction or similar technique may be needed to avoid the problem of multiple comparisons. Most importantly, the distinction between statistical and clinical significance cannot be overestimated. Reporting of 95% confidence intervals and a priori establishment of clinically meaningful differences is recommended. The most valuable presentation of results uses raw data. Presenting raw data in tabular form for larger studies is most appropriate in the online supplemental appendix now widely available.
Conclusions
We recommend a standardized and comprehensive approach to the reporting of OSA surgery trials. These standards will help in the analysis of individual study outcomes and the determination of treatment effectiveness.
